PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer
Work
Year: 2019
Type: article
Source: Journal of Thoracic Oncology
Authors Marcelo V. Negrão, Vincent K. Lam, Alexandre Reuben, Maria Laura Rubin, L.L. Landry +13 more
Cites: 39
Cited by: 88
Related to: 10
FWCI: 7.066
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze